Latest News for: phase 1 clinical trial

Edit

Early Phase Clinical Trial Outsourcing Research Report 2026: $14.8 Bn Market Opportunities, Trends, Competitive Landscape, ...

Nasdaq Globe Newswire 24 Apr 2026
The early phase clinical trial outsourcing market presents opportunities driven by rising personalized medicine focus, ...
Edit

Last patient, last visit completed in Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment ...

Nasdaq Globe Newswire 23 Apr 2026
-Results to be presented at ARVO 2026 Annual Meeting- ... .
Edit

Last patient, last visit completed in Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Pharmiweb 23 Apr 2026
Last patient, last visit completed in Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA).
Edit

Site Management Organization Market Report 2026-2035 with Insights by Therapeutic Area, Trial Phases, Clinical Trial ...

Nasdaq Globe Newswire 20 Apr 2026
... (SMO) market is set for robust growth, driven by rising clinical trial complexity and volume.
Edit

Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases

The Galveston Daily News 20 Apr 2026
TOKYO--(BUSINESS WIRE)--Apr 20, 2026-- ....
Edit

PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner

The Galveston Daily News 20 Apr 2026
KAWASAKI, Japan--(BUSINESS WIRE)--Apr 20, 2026-- ....
Edit

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an

The Eagle-Tribune 20 Apr 2026
Second candidate from Tenvie’s product engine to enter clinical development ... .
Edit

Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases (Asahi Kasei Corporation)

Public Technologies 20 Apr 2026
Asahi Kasei, a diversified global company, today announced the initiation of a Phase I clinical trial for AK1940, a novel peptide-based investigational compound developed to address significant unmet ...
Edit

Luye Pharma Announces First Subject Enrolled in China Phase Ⅱ Clinical Trial of LY03017 (5-HT2AR/5-HT2CR) for Alzheimer’s ... (Luye Pharma Group Ltd)

Public Technologies 16 Apr 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 130968584) .
Edit

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage ...

Nasdaq Globe Newswire 15 Apr 2026
78% Objective Response Rate (ORR) with PDS01ADC; Parallel trial without PDS01ADC had 35% ORR 2-year survival rate of >80%; Parallel trial without PDS01ADC resulted in 2-year survival rate of ~35% ... .
Edit

Samsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate (ADC) Candidate

Al Bawaba 15 Apr 2026
announced today the initiation of Phase 1 clinical trial for SBE303.
Edit

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial (Form 8-K) (PDS Biotechnology Corporation)

Public Technologies 15 Apr 2026
) PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial.
Edit

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, ...

The Galveston Daily News 13 Apr 2026
WATERTOWN, Mass.--(BUSINESS WIRE)--Apr 13, 2026-- ....
Edit

Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090

Nasdaq Globe Newswire 13 Apr 2026
AKB-9090 is being evaluated as a potential treatment for cardiac surgery-associated acute kidney injury. AKB-9090 is being evaluated as a potential treatment for cardiac surgery-associated acute kidney injury ... .
Edit

Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R ...

Nasdaq Globe Newswire 13 Apr 2026
Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers ... .

Article Search

tools
×
×
×
×